Learn More
CERILLIANT™ Sibutramine Hydrochloride Solution, 1.0 mg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco S0111ML
Description
Sibutramine, a SNRI and anorectant, was marketed as a treatment for obesity until 2010 when it was removed from the market over concerns of potential adverse cardiovascular side effects. Sold under trade names Reductil, Meridia™, and Subitrex, this sibutramine Snap-N-Spike™ reference solution is applicable for use in LC/MS or GC/MS applications for clinical toxicology and forensic analysis.
Specifications
| 67-56-1 , 84485-00-7 | |
| MFCD04039806 | |
| 1.0 mg/mL in methanol (as free base) | |
| 316.31 | |
| 1 mL |
| C17H26ClN · HCl | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| Sibutramine hydrochloride monohydrate, 1-(4-Chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)cyclobutanemethanamine hydrochloride monohydrate, Meridia, Reductil | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation